S. Weikert

819 total citations
35 papers, 449 citations indexed

About

S. Weikert is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, S. Weikert has authored 35 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 12 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in S. Weikert's work include Renal cell carcinoma treatment (9 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Testicular diseases and treatments (5 papers). S. Weikert is often cited by papers focused on Renal cell carcinoma treatment (9 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Testicular diseases and treatments (5 papers). S. Weikert collaborates with scholars based in Germany, United States and Netherlands. S. Weikert's co-authors include K. Miller, Frank Christoph, Carsten Kempkensteffen, Martin Schostak, M. Schrader, Hans Krause, Viktor Grünwald, Jens Köllermann, Jonas Busch and Stefan Hinz and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Epidemiology and British Journal of Cancer.

In The Last Decade

S. Weikert

34 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Weikert Germany 12 260 225 106 88 68 35 449
Ana Rodríguez Spain 6 170 0.7× 183 0.8× 106 1.0× 100 1.1× 103 1.5× 10 449
Zhizhi Hu China 10 239 0.9× 166 0.7× 119 1.1× 46 0.5× 19 0.3× 16 468
Jianliang Wu China 7 149 0.6× 153 0.7× 94 0.9× 38 0.4× 62 0.9× 17 393
A. Celma Spain 13 170 0.7× 530 2.4× 149 1.4× 64 0.7× 98 1.4× 97 727
Çiğdem Usul Afşar Türkiye 14 123 0.5× 75 0.3× 63 0.6× 71 0.8× 178 2.6× 50 438
Kiat Tsong Tan United Kingdom 9 134 0.5× 67 0.3× 92 0.9× 82 0.9× 84 1.2× 20 420
Zhiqiang Yin China 13 173 0.7× 90 0.4× 91 0.9× 138 1.6× 79 1.2× 32 484
Nariaki Asada Japan 9 207 0.8× 96 0.4× 56 0.5× 45 0.5× 24 0.4× 17 471
Prakash Chelladurai Germany 10 219 0.8× 276 1.2× 135 1.3× 32 0.4× 51 0.8× 15 450

Countries citing papers authored by S. Weikert

Since Specialization
Citations

This map shows the geographic impact of S. Weikert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Weikert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Weikert more than expected).

Fields of papers citing papers by S. Weikert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Weikert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Weikert. The network helps show where S. Weikert may publish in the future.

Co-authorship network of co-authors of S. Weikert

This figure shows the co-authorship network connecting the top 25 collaborators of S. Weikert. A scholar is included among the top collaborators of S. Weikert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Weikert. S. Weikert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doehn, Christian, Lothar Bergmann, John L. Decker, et al.. (2024). Aktualisierte S3-Leitlinie Nierenzellkarzinom. PubMed. 63(5). 439–447. 1 indexed citations
2.
Ebbing, Jan, Carsten Kempkensteffen, K. Miller, et al.. (2015). Evaluation of perioperative complications in open and laparoscopic surgery for renal cell cancer with tumor thrombus involvement using the Clavien–Dindo classification. European Journal of Surgical Oncology. 41(7). 941–952. 26 indexed citations
3.
Grünwald, Viktor, S. Weikert, I G Schmidt-Wolf, et al.. (2014). Aset Study: Final Results of Patients with Locally Recurrent or Metastatic Renal Cell Carcinoma (Rcc) Treated with Mgn1601. Annals of Oncology. 25. iv366–iv366. 2 indexed citations
4.
Seidel, Christoph, Jonas Busch, S. Weikert, et al.. (2013). Tumour shrinkage measured with first treatment evaluation under VEGF-targeted therapy as prognostic marker in metastatic renal cell carcinoma (mRCC). British Journal of Cancer. 109(12). 2998–3004. 26 indexed citations
5.
Weikert, S., D. Baumunk, Carsten Stephan, et al.. (2011). Etablierung von interdisziplinären Prostatakrebszentren nach den Empfehlungen der DKG. Der Urologe. 50(9). 1083–1088. 4 indexed citations
6.
Grünwald, Viktor, Christoph Seidel, Martin Fenner, et al.. (2011). Treatment of everolimus-resistant metastatic renal cell carcinoma with VEGF-targeted therapies. British Journal of Cancer. 105(11). 1635–1639. 25 indexed citations
7.
Gruenwald, Viktor, Christoph Seidel, Jonas Busch, Martin Fenner, & S. Weikert. (2011). Second-line everolimus treatment is effective in RCC patients with poor progression-free survival (PFS) in first-line VEGF-targeted therapies.. Journal of Clinical Oncology. 29(15_suppl). e15028–e15028. 2 indexed citations
8.
Johannsen, Manfred, Michael Staehler, Anne Flörcken, et al.. (2010). Outcome of treatment discontinuation in patients with metastatic renal cell carcinoma and no evidence of disease following targeted therapy with or without metastasectomy. Annals of Oncology. 22(3). 657–663. 40 indexed citations
9.
Busch, Jonas, Christoph Röllig, L. Weißbach, et al.. (2009). Entscheidend ist, was ankommt. Der Urologe. 49(1). 75–80. 5 indexed citations
10.
Hinz, Stefan, Carsten Kempkensteffen, Frank Christoph, et al.. (2008). Expression Parameters of the Polycomb Group Proteins BMI1, SUZ12, RING1 and CBX7 in Urothelial Carcinoma of the Bladder and Their Prognostic Relevance. Tumor Biology. 29(5). 323–329. 48 indexed citations
11.
Weikert, S., et al.. (2008). Picrotoxin in der Therapie des Morbus Menière. Laryngo-Rhino-Otologie. 87(12). 862–866. 1 indexed citations
12.
Weikert, S., et al.. (2008). Zervikopropriozeptive Provokation von horizontalen und vertikalen Nystagmen bei Probanden. HNO. 56(10). 1013–1019. 3 indexed citations
13.
Hinz, Stefan, Carsten Kempkensteffen, S. Weikert, et al.. (2007). EZH2 Polycomb Transcriptional Repressor Expression Correlates with Methylation of the APAF-1 Gene in Superficial Transitional Cell Carcinoma of the Bladder. Tumor Biology. 28(3). 151–157. 18 indexed citations
14.
Weikert, S., et al.. (2007). Low-frequency distortion product otoacoustic emission test compared to ECoG in diagnosing endolymphatic hydrops. European Archives of Oto-Rhino-Laryngology. 265(6). 643–649. 8 indexed citations
15.
Christoph, Frank, Carsten Kempkensteffen, S. Weikert, et al.. (2006). Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer. British Journal of Cancer. 95(12). 1701–1707. 74 indexed citations
16.
Schostak, Martin, Hans Krause, K. Miller, et al.. (2006). Quantitative real-time RT-PCR of CD24 mRNA in the detection of prostate cancer. BMC Urology. 6(1). 7–7. 20 indexed citations
17.
Christoph, Frank, Carsten Kempkensteffen, S. Weikert, et al.. (2006). Frequent epigenetic inactivation of p53 target genes in seminomatous and nonseminomatous germ cell tumors. Cancer Letters. 247(1). 137–142. 17 indexed citations
18.
Kempkensteffen, Carsten, Stefan Hinz, Frank Christoph, et al.. (2006). Rektumperforation als Spätkomplikation einer ProACT-Implantation. Der Urologe. 45(7). 865–867. 4 indexed citations
19.
Christoph, Frank, S. Weikert, K. Miller, & M. Schrader. (2005). New Guidelines for Clinical Stage I Testicular Seminoma?. Oncology. 69(6). 455–462. 3 indexed citations
20.
Christoph, Frank, et al.. (2005). How septic is urosepsis? Clinical course of infected hydronephrosis and therapeutic strategies. World Journal of Urology. 23(4). 243–247. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana Rodríguez Breakdown of academic impact, for papers by Zhizhi Hu Breakdown of academic impact, for papers by Jianliang Wu Breakdown of academic impact, for papers by A. Celma Breakdown of academic impact, for papers by Çiğdem Usul Afşar Breakdown of academic impact, for papers by Kiat Tsong Tan Breakdown of academic impact, for papers by Zhiqiang Yin Breakdown of academic impact, for papers by Nariaki Asada Breakdown of academic impact, for papers by Prakash Chelladurai
Rankless by CCL
2026